The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment of metastatic human papillomavirus-associated epithelial cancers with adoptive transfer of tumor-infiltrating T cells.
 
Sanja Stevanovic
Patents, Royalties, Other Intellectual Property - NIH/NCI; NIH/NCI (Inst)
 
Sarah R. Helman
No Relationships to Disclose
 
John R. Wunderlich
No Relationships to Disclose
 
Michelle M. Langhan
No Relationships to Disclose
 
Stacey L. Doran
No Relationships to Disclose
 
Mei Li M. Kwong
No Relationships to Disclose
 
Robert P. Somerville
No Relationships to Disclose
 
Christopher Austin Klebanoff
Stock and Other Ownership Interests - Bluebird Bio; Bristol-Myers Squibb; Celgene; CVS Health; DaVita; Gilead Sciences
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Bristol-Myers Squibb; Cell Design Labs; Obsidian Therapeutics; RXI Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst); Lilly (Inst); Roche/Genentech (Inst)
 
Udai Kammula
No Relationships to Disclose
 
Richard Mark Sherry
No Relationships to Disclose
 
James C. Yang
No Relationships to Disclose
 
Steven A. Rosenberg
Research Funding - Kite/Gilead (Inst)
Patents, Royalties, Other Intellectual Property - Kite Pharma - CRADA Royalties (Inst)
 
Christian S. Hinrichs
Employment - MedImmune (I)
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Patents in the field of cell therapy that are held by the NIH.; Royalties from patents that are held by the NIH.